Menu
← Oncology Approval Tracker
FDA DECISION ·
Afatinib tablets
afatinib dimaleate · Hetero Labs / Apotex
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generics of Gilotrif for first-line metastatic NSCLC with qualifying non-resistant EGFR mutations, and for metastatic squamous NSCLC progressing after platinum-based chemotherapy.
LAMPGEN ANALYSIS
Why it matters
These approvals add generic options for afatinib tablets. Separate the two lung cancer uses, which have different biomarker and prior-treatment requirements.
What research teams should watch
Record the approved product, exact EGFR result when applicable, and distribution availability. Check site formularies before attributing any access change to the approval.
PRIMARY RECORDS